Own the gold standard ✨ in financial data & analytics

Subscribe for $2
Overview
Profile

RenovaCare Company

RCAR
US75988J1060
A1XB0J

Price

0.00
Today +/-
+0
Today %
+0 %
P

RenovaCare stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the RenovaCare stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the RenovaCare stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the RenovaCare stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze RenovaCare's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

RenovaCare Stock Price History

DateRenovaCare Price
10/23/20240.00 undefined
10/17/20240.00 undefined
10/8/20240.00 undefined
10/2/20240.00 undefined

RenovaCare Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into RenovaCare, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by RenovaCare from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects RenovaCare’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of RenovaCare. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into RenovaCare’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing RenovaCare’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on RenovaCare’s growth potential.

RenovaCare Revenue, EBIT and net profit per share

DateRenovaCare RevenueRenovaCare EBITRenovaCare Net Income
20210 undefined-5.41 M undefined-4.47 M undefined
20200 undefined-9.68 M undefined-9.55 M undefined
20190 undefined-3.69 M undefined-3.36 M undefined
20180 undefined-2.01 M undefined-2.12 M undefined
20170 undefined-2.7 M undefined-3.69 M undefined
20160 undefined-1.9 M undefined-2.08 M undefined
20150 undefined-1.32 M undefined-1.32 M undefined
20140 undefined-2.13 M undefined-2.13 M undefined
20130 undefined-630,000 undefined-1.03 M undefined
201220,000 undefined-240,000 undefined-240,000 undefined
201130,000 undefined-790,000 undefined4.46 M undefined
201040,000 undefined-310,000 undefined-4.27 M undefined
200950,000 undefined-300,000 undefined1.27 M undefined
200810,000 undefined-190,000 undefined-270,000 undefined
20070 undefined-30,000 undefined-30,000 undefined
20060 undefined-80,000 undefined-50,000 undefined
20050 undefined-70,000 undefined-70,000 undefined
20040 undefined-180,000 undefined-170,000 undefined
20030 undefined-710,000 undefined-700,000 undefined
2002920,000 undefined-280,000 undefined-260,000 undefined

RenovaCare Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021
000000000000000000000000
------------------------
------------------------
000000000000000000000000
0000000000000000-2-1-1-2-2-3-9-5
------------------------
000000000001-440-1-2-1-2-3-2-3-9-4
-------------500.00-200.00--100.00-50.00100.0050.00-33.3350.00200.00-55.56
23.0523.2449.261.972.6716.196.6396.6396.6396.5259.3763.0863.0863.0863.0863.466.5867.2369.7774.3977.7587.2487.3587.35
------------------------
Details

Keystats

ⓘ

Revenue and Growth

The RenovaCare Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the RenovaCare is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (k)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (k)CURRENT ASSETS (M)TANGIBLE ASSETS (k)LONG-T. INVEST. (M)LONG-T. REC. (k)INTANGIBLE ASSETS (k)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (k)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (k)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021
                                               
1.231.910.940.830.850.290.130.0800.052.742.412.050.790.511.510.680.40.422.9115.412.197.412.85
001501500000000100100000000000
000000000000000000000000
000000000000000000000000
0000100000000001007.4510.2931.540.75168.71102.5566.28533.45
1.231.911.090.980.860.290.130.0800.052.742.422.050.80.521.510.690.410.452.9115.5712.297.983.38
102003101701803020000350100305405400000.90.580.260118.157.9
00000.060.190.321.490000000000000000
00000000800000008000000000
05040000000000000160162.85152.85152.85152.85152.85152.85152.85152.85
000000000000000000000000
000504000000000000000000145.7458.74
0.010.250.350.220.280.220.341.490.0800.350.10.030.540.540.240.160.150.150.150.150.150.420.27
1.242.161.441.21.140.510.471.570.080.053.092.522.081.341.061.750.850.560.63.0615.7212.448.43.65
                                               
000000000000000000000000
2.043.583.563.563.843.843.843.843.843.847.115.55.465.465.467.228.139.211.2916.432.1932.3836.8536.59
-0.83-1.54-2.23-2.54-2.81-3.51-3.68-3.75-3.79-3.82-4.08-4.44-8.7-4.25-4.49-5.52-7.66-8.97-11.05-14.74-16.86-20.22-29.77-34.24
00.08000.010.140.271.440000000000000000
000000000000000000000000
1.212.121.331.021.040.470.431.530.050.023.031.06-3.241.210.971.70.470.220.241.6615.3312.167.082.35
0.020.020.0200.020.040.030.020.0200.050.030.010.030.040.050.010.10.030.170.230.281.241.27
0090190500020202010101050000015.2290.68167.5051.1330.5
000000000001.385.250000.190.130.150.10000
000000000000000000165.4800000
0000100000000000000000000
0.020.020.110.190.080.040.030.040.040.020.061.425.270.080.040.050.190.240.360.360.390.281.291.31
00000.02000000000000001.040000
000000000000000000000000
000000000004050606000100000028.610
00000.020000000.040.050.060.06000.101.04000.030
0.020.020.110.190.10.040.030.040.040.020.061.465.320.140.10.050.190.340.361.40.390.281.321.31
1.232.141.441.211.140.510.461.570.090.043.092.522.081.351.071.750.670.560.63.0615.7212.448.43.65
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of RenovaCare provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand RenovaCare's financial health and stability.

Assets

RenovaCare's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that RenovaCare must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of RenovaCare after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into RenovaCare's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021
000000000001-440-1-2-1-2-3-2-3-9-4
000000000000000000000000
000000000000000000000000
000000000000000000000000
00000000000-13-50000010040
000000000000000000000000
000000000000000000000000
00000000000000000-1-1-1-2-3-4-4
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
0100000000300001011314000
0100000000300001011414000
------------------------
000000000000000000000000
0000000000200-101000212-3-4-4
-0.2-0.94-0.69-0.070.02-0.54-0.17-0.05-0.080.05-0.51-0.32-0.36-1.27-0.28-0.51-0.83-1.3-1.79-1.67-2.03-3.21-4.76-4.56
000000000000000000000000

RenovaCare stock margins

The RenovaCare margin analysis displays the gross margin, EBIT margin, as well as the profit margin of RenovaCare. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for RenovaCare.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the RenovaCare's sales revenue. A higher gross margin percentage indicates that the RenovaCare retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the RenovaCare's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the RenovaCare's total revenue generated. When comparing the revenue margin year over year, investors can gauge the RenovaCare's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the RenovaCare. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the RenovaCare's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

RenovaCare Margin History

RenovaCare Gross marginRenovaCare Profit marginRenovaCare EBIT marginRenovaCare Profit margin
202133.33 %0 %0 %
202033.33 %0 %0 %
201933.33 %0 %0 %
201833.33 %0 %0 %
201733.33 %0 %0 %
201633.33 %0 %0 %
201533.33 %0 %0 %
201433.33 %0 %0 %
201333.33 %0 %0 %
201233.33 %-1,200 %-1,200 %
201133.33 %-2,633.33 %14,866.67 %
201025 %-775 %-10,675 %
200920 %-600 %2,540 %
2008100 %-1,900 %-2,700 %
200733.33 %0 %0 %
200633.33 %0 %0 %
200533.33 %0 %0 %
200433.33 %0 %0 %
200333.33 %0 %0 %
200275 %-30.43 %-28.26 %

RenovaCare Stock Sales Revenue, EBIT, Earnings per Share

The RenovaCare earnings per share therefore indicates how much revenue RenovaCare has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue RenovaCare earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates RenovaCare's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of RenovaCare’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating RenovaCare's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

RenovaCare Revenue, EBIT and net profit per share

DateRenovaCare Sales per ShareRenovaCare EBIT per shareRenovaCare Earnings per Share
20210 undefined-0.06 undefined-0.05 undefined
20200 undefined-0.11 undefined-0.11 undefined
20190 undefined-0.04 undefined-0.04 undefined
20180 undefined-0.03 undefined-0.03 undefined
20170 undefined-0.04 undefined-0.05 undefined
20160 undefined-0.03 undefined-0.03 undefined
20150 undefined-0.02 undefined-0.02 undefined
20140 undefined-0.03 undefined-0.03 undefined
20130 undefined-0.01 undefined-0.02 undefined
20120 undefined-0 undefined-0 undefined
20110 undefined-0.01 undefined0.07 undefined
20100 undefined-0 undefined-0.07 undefined
20090 undefined-0 undefined0.02 undefined
20080 undefined-0 undefined-0 undefined
20070 undefined-0 undefined-0 undefined
20060 undefined-0 undefined-0 undefined
20050 undefined-0 undefined-0 undefined
20040 undefined-0 undefined-0 undefined
20030 undefined-0.04 undefined-0.04 undefined
20020.34 undefined-0.1 undefined-0.1 undefined

RenovaCare business model

RenovaCare Inc is an American company based in New York that specializes in the development of innovative medical products. The company was founded by Dr. Walter Schmidt in 2004 and has since experienced remarkable growth. RenovaCare Inc's main business model is to develop cutting-edge technologies and treatment methods for the healing of severe skin injuries and other wounds. RenovaCare's products include advanced wound care systems as well as innovative treatment procedures for rapid and effective skin regeneration. The history of RenovaCare Inc began with the development of the SkinGun, a groundbreaking device for the healing of severe skin injuries and burns. The SkinGun is used to collect precious skin cells from the patient, which are then grown in a laboratory and applied directly to the injured area. This technology provides a faster and gentler alternative to traditional skin grafting methods. RenovaCare Inc has expanded its business activities to include other areas, including the field of Medical Aesthetics. For example, the company has developed an innovative procedure for reducing wrinkles and skin tightening, which is marketed under the name CellMist. Another division of the company is the development of state-of-the-art cell culture and cryopreservation devices. These product lines allow for the efficient production and transfer of stem cells and other autologous cells for laboratory and medical purposes. RenovaCare has also specialized in the research and development of therapies for neurological diseases and injuries. These include procedures for the treatment of Parkinson's, Alzheimer's, and ALS. In recent years, RenovaCare Inc has become a leading company in the field of regenerative medicine. The company works closely with renowned universities, research institutions, and companies to keep its innovative technology up to date. The company has received numerous patents for its innovative technologies and products in recent years. RenovaCare is particularly known for its groundbreaking achievements in the field of regenerative medicine. RenovaCare Inc has experienced solid growth in recent years and is now one of the leading companies in the field of regenerative medicine. The company has focused its efforts on research and development of products that make the healing process for skin injuries and wounds as fast and effective as possible. RenovaCare's products are internationally known and used by patients around the world. RenovaCare will continue its commitment to research and development and further expand its position as a pioneer in regenerative medicine. RenovaCare is one of the most popular companies on Eulerpool.com.

RenovaCare SWOT Analysis

Strengths

RenovaCare Inc is a biotechnology company specializing in developing innovative and advanced therapies for wound healing and skin regeneration. The company's strengths include:

  • Extensive research and development capabilities in the field of regenerative medicine.
  • Patented technology, SkinGun™, that enables spray-on skin cell regeneration for fast and effective wound healing.
  • Strong intellectual property portfolio protecting their innovative products and technologies.
  • Collaboration with renowned scientific institutions, facilitating knowledge exchange and access to expertise.
  • Established partnerships with healthcare organizations, enhancing distribution channels and market reach.

Weaknesses

Despite its strengths, RenovaCare Inc also faces certain weaknesses that could hinder its growth and success:

  • Relatively high research and development costs associated with developing and commercializing cutting-edge medical technologies.
  • Dependency on limited product lines, which may increase vulnerability to market fluctuations and competition.
  • Limited financial resources, potentially impacting their ability to scale operations and expand into new markets.
  • Regulatory challenges and stringent approval processes for new medical treatments, leading to potential delays in product commercialization.

Opportunities

RenovaCare Inc has opportunities to capitalize on the market demand and technological advancements in regenerative medicine:

  • Increasing global prevalence of chronic wounds and burns, creating a significant market potential for advanced wound healing solutions.
  • Growing adoption of regenerative medicine and stem cell therapies in the healthcare sector, providing a favorable market environment.
  • Expanding product portfolio by leveraging the SkinGun™ technology for potential applications in cosmetic surgeries and dermatology.
  • Exploring international markets and strategic partnerships to enhance global presence and access new customer segments.

Threats

RenovaCare Inc faces several threats that could impact its growth and competitive position in the market:

  • Intense competition in the regenerative medicine and wound healing industry from established players and emerging startups.
  • Potential negative regulatory decisions or legal constraints on the use of stem cell therapies and associated technologies.
  • Economic uncertainties and market volatility that could affect healthcare spending and investment in advanced medical treatments.
  • Rapid technological advancements leading to the development of alternative and potentially superior wound healing solutions.

RenovaCare Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

RenovaCare historical P/E ratio, EBIT multiple, and P/S ratio

RenovaCare shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue RenovaCare earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates RenovaCare's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of RenovaCare’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating RenovaCare's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

RenovaCare stock splits

In RenovaCare's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for RenovaCare.

RenovaCare shareholders

%
Name
Stocks
Change
Date
0 % CAPTRUST Financial Advisors0-5,0009/30/2022
1

RenovaCare Executives and Management Board

Dr. Robin Robinson66
RenovaCare Chief Scientific Officer
Compensation 220,000
Mr. Harmel Rayat62
RenovaCare Chairman of the Board, Interim President, Chief Executive Officer, Interim Chief Financial Officer, Secretary (since 1996)
Compensation 1
1

RenovaCare Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Thermo Fisher Scientific Stock
Thermo Fisher Scientific
SupplierCustomer0,400,350,380,83-0,35-0,76
Roche Holding Stock
Roche Holding
SupplierCustomer-0,670,87-0,220,12-0,40-0,85
1

Most common questions regarding RenovaCare

What values and corporate philosophy does RenovaCare represent?

RenovaCare Inc represents values of innovation, patient-centric care, and technological advancement in the field of regenerative medicine. The company's corporate philosophy is centered around providing cutting-edge solutions for patients with severe burns, wounds, and other skin-related conditions. RenovaCare Inc aims to revolutionize the traditional approach to wound healing by utilizing its patented CellMist System, which allows for the gentle and efficient harvesting of a patient's own skin cells for subsequent spray-on application. With a focus on improving patient outcomes and enhancing quality of life, RenovaCare Inc remains committed to developing novel therapies and setting new standards in the field of regenerative medicine.

In which countries and regions is RenovaCare primarily present?

RenovaCare Inc is primarily present in the United States.

What significant milestones has the company RenovaCare achieved?

RenovaCare Inc has achieved several significant milestones. One of the major achievements is the development of their innovative SkinGun technology, which allows for the spraying of a patient's own stem cells onto burn wounds, promoting faster healing and recovery. Additionally, the company successfully conducted multiple clinical trials, demonstrating the efficacy of their technology in treating burns and other skin injuries. RenovaCare Inc also received recognition and awards for their breakthrough innovations, including the Frost & Sullivan's Technology Innovation Leadership Award. These milestones highlight the company's dedication to revolutionizing skin regeneration and positioning them as a leader in the field.

What is the history and background of the company RenovaCare?

RenovaCare Inc is a biotechnology company specializing in the development and commercialization of innovative medical devices for wound healing and tissue regeneration. Founded in 2004, RenovaCare focuses on utilizing its patented SkinGun™ technology to spray a patient's own regenerative cells on burn and wound injuries, promoting faster healing and reduced scarring. RenovaCare's mission is to improve the quality of life for patients and revolutionize the field of regenerative medicine. With a strong emphasis on research and development, RenovaCare is committed to advancing its technologies to address unmet medical needs and have a positive impact on the healthcare industry.

Who are the main competitors of RenovaCare in the market?

The main competitors of RenovaCare Inc in the market include Avita Medical Ltd, Misonix Inc, and PolarityTE Inc.

In which industries is RenovaCare primarily active?

RenovaCare Inc is primarily active in the medical devices industry.

What is the business model of RenovaCare?

The business model of RenovaCare Inc involves developing medical-grade technologies that aim to address the limitations of current wound care methods. The company is focused on the research, development, and commercialization of its proprietary CellMist™ System. This patented technology is designed to use a patient's own skin cells to create a Spray-On Skin™ solution, which can be applied to wounds to facilitate faster and more effective healing. RenovaCare aims to provide a non-invasive, cost-effective, and painless solution for patients suffering from burns, chronic wounds, and other skin-related conditions, with the ultimate goal of improving quality of life for individuals in need of advanced wound care treatment.

What is the P/E ratio of RenovaCare 2024?

The P/E ratio cannot be calculated for RenovaCare at the moment.

What is the P/S ratio of RenovaCare 2024?

The P/S cannot be calculated for RenovaCare currently.

What is the Quality Investing of RenovaCare?

The Quality Investing for RenovaCare is 3/10.

What is the revenue of RenovaCare 2024?

The revenue cannot currently be calculated for RenovaCare.

How high is the profit of RenovaCare 2024?

The profit cannot currently be calculated for RenovaCare.

What is the business model of RenovaCare

RenovaCare Inc. is a biopharmaceutical company from the USA that specializes in the development and commercialization of innovative therapeutics and medical products. The company focuses particularly on the regeneration of human tissue. RenovaCare aims to revolutionize the regeneration of skin tissue by offering innovative and safe therapy options. One of RenovaCare's most important areas of focus is the development of innovative products for the treatment of severe skin injuries and wounds. In particular, autologous cell therapy is an important approach. The company uses a patented technology called "Spray-On Skin" to naturally regenerate skin tissue using the patient's own cells. Cells are obtained from a small skin sample of the patient and processed in a specialized procedure in a matter of hours. The cells are then applied to the affected areas of the skin using a spray device, where they grow into natural, healthy skin. RenovaCare also offers a special device called the SkinGun, which allows for quick and easy implementation of autologous cell therapy. The device is compact and user-friendly, which is particularly advantageous in emergency medicine. Another important focus area for RenovaCare is the development of innovative products for burn treatment. This includes the patented "Spray-On Burn Treatment," which enables the quick and simple treatment of burns. In this procedure as well, the patient's own cells are used to regenerate the affected tissue. Furthermore, RenovaCare has a team of highly qualified scientists and researchers who collaborate closely with leading universities and institutes to develop new and innovative solutions in the field of human tissue regeneration. Thanks to this collaboration, RenovaCare is able to continuously drive groundbreaking developments and bring new therapy options to the market. RenovaCare's business model is based on the development and commercialization of innovative therapeutics and medical products for human tissue regeneration. The company utilizes the use of autologous cells to enable natural regeneration. RenovaCare collaborates closely with leading scientists and researchers and has a team of highly skilled professionals to drive its innovations. Overall, RenovaCare is an innovative company specializing in the development of therapeutics and medical products for human tissue regeneration. Through high-quality research and development work, the company is able to continuously develop groundbreaking solutions and bring new therapy options to the market.

What is the RenovaCare dividend?

RenovaCare pays a dividend of 0 USD distributed over payouts per year.

How often does RenovaCare pay dividends?

The dividend cannot currently be calculated for RenovaCare or the company does not pay out a dividend.

What is the RenovaCare ISIN?

The ISIN of RenovaCare is US75988J1060.

What is the RenovaCare WKN?

The WKN of RenovaCare is A1XB0J.

What is the RenovaCare ticker?

The ticker of RenovaCare is RCAR.

How much dividend does RenovaCare pay?

Over the past 12 months, RenovaCare paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, RenovaCare is expected to pay a dividend of 0 USD.

What is the dividend yield of RenovaCare?

The current dividend yield of RenovaCare is .

When does RenovaCare pay dividends?

RenovaCare pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of RenovaCare?

RenovaCare paid dividends every year for the past 0 years.

What is the dividend of RenovaCare?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is RenovaCare located?

RenovaCare is assigned to the 'Health' sector.

Wann musste ich die Aktien von RenovaCare kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of RenovaCare from 11/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.

When did RenovaCare pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of RenovaCare in the year 2023?

In the year 2023, RenovaCare distributed 0 USD as dividends.

In which currency does RenovaCare pay out the dividend?

The dividends of RenovaCare are distributed in USD.

All fundamentals about RenovaCare

Our stock analysis for RenovaCare Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of RenovaCare Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.